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supplementation with either beta-alanine or placebo, and 
after an 11-days HIt block (9 sessions, 4 × 4 min), which 
followed supplementation. carnosine was assessed via 
Mr spectroscopy. Energy contribution during 90-s severe 
cycling was estimated from the O2 deficit. Biopsies from m. 
vastus lateralis were taken before and after the test.
Results Beta-alanine increased leg muscle carnos-
ine (32 ± 13 %, d = 3.1). Buffering capacity and incre-
mental cycling were unaffected, but during 90-s severe 
cycling, beta-alanine increased aerobic energy contribution 
(1.4 ± 1.3 %, d = 0.5), concurrent with reduced O2 defi-
cit (−5.0 ± 5.0 %, d = 0.6) and muscle lactate accumula-
tion (−23 ± 30 %, d = 0.9), while having no effect on pH. 
Beta-alanine also enhanced motivation and perceived state 
during the HIt block. there were no between-group differ-
ences in adaptations to the training block, namely increased 
buffering capacity (+7.9 ± 11.9 %, p = 0.04, d = 0.6, 
n = 14) and glycogen storage (+30 ± 47 %, p = 0.04, 
d = 0.5, n = 16).
Conclusions Beta-alanine did not affect buffering consid-
erably, but has beneficial effects on severe exercise metabo-
lism as well as psychological parameters during intense 
training phases.
Keywords carnosine · Muscle buffering capacity · Block 
training · glycogen
Introduction
Sporting events lasting between 60 and ~240 s; for exam-
ple, in middle distance running, speed skating and alpine 
skiing, power output exceeds that corresponding to maxi-
mal oxygen uptake (VO2max) (Billat et al. 2009; de Kon-
ing et al. 2005; Ferguson 2010). For abrupt transitions at 
Abstract 
Introduction We aimed to manipulate physiological deter-
minants of severe exercise performance. We hypothesized 
that (1) beta-alanine supplementation would increase intra-
muscular carnosine and buffering capacity and dampen aci-
dosis during severe cycling, (2) that high-intensity interval 
training (HIt) would enhance aerobic energy contribution 
during severe cycling, and (3) that HIt preceded by beta-
alanine supplementation would have greater benefits.
Methods Sixteen active men performed incremen-
tal cycling tests and 90-s severe (110 % peak power) 
cycling tests at three time points: before and after oral 
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the start and at overall intensities in the severe domain 
(i.e., above the maximal oxygen uptake, VO2max), aerobic 
energy provision is insufficient, and large amounts of AtP 
must be drawn from substrate-level phosphorylation, which 
entails increasing metabolite accumulation and is a cause 
of muscular fatigue (Jones et al. 2010). thus, two options 
for improving performance in such events are enhancing 
aerobic contribution to power output (Demarle et al. 2001; 
Duffield et al. 2006; Weston et al. 1997) or improving the 
ability to counteract accumulation of fatigue-inducing 
metabolites (Messonnier et al. 2007).
High-intensity interval training (HIt) performed at an 
intensity near VO2max effectively speeds VO2 on-kinetics 
and increases VO2max and the critical power in trained 
persons (Billat et al. 2002; Breil et al. 2010; Demarle et al. 
2001; gross et al. 2007; Vanhatalo et al. 2008). these adap-
tations favor aerobic energy production in the severe exer-
cise domain (Duffield et al. 2006; Weber and Schneider 
2002). Further, HIt can improve skeletal muscle buffer-
ing capacity (Weston et al. 1997), minimizing the effects 
of accumulating protons, one suggested fatigue-inducing 
metabolite during severe exercise of a few minutes (carr 
et al. 2011). In accord with this enhanced aerobic energy 
supply and curbed acidosis, improvements in severe exer-
cise time-to-exhaustion (Weston et al. 1997) and perfor-
mance (gross et al. 2007; Stepto et al. 1999) have been 
shown following short blocks of HIt.
Oral supplementation with the amino acid beta-alanine 
leads to increases in muscle carnosine (Derave et al. 2007; 
Harris et al. 2006; Hill et al. 2007), a molecule which has 
positive effects on muscle function during exercise. For 
example, carnosine is a proton buffer in the physiological 
pH range (Abe 2000; Boldyrev 2000) and is therefore capa-
ble of lessening exercise-induced acidosis and acidosis-
induced fatigue. As well, carnosine can counteract fatigue-
related events such as drops in ca2+ release (shown in 
human type I fibers) and ca2+ sensitivity of the contractile 
apparatus (in both fiber types) (Dutka et al. 2012), effects 
which are entirely independent of acidosis (as pH was fixed 
at 7.1 in the cited studies). While the addition of carnosine 
has little effect on maximal force, increases in ca2+ sensi-
tivity are important for maintaining force output when it is 
reduced to submaximal levels with fatigue. In accord with 
these proposed effects on buffering and muscle function, 
supplementation with high doses (~10–20 times the normal 
daily intake) of isolated beta-alanine has previously been 
shown to improve exercise capacity in a 30-s cycling sprint 
(Van thienen et al. 2009), repeated 30-s isokinetic knee 
extensions (Derave et al. 2007) and cycling time-to-exhaus-
tion at 110 % VO2max (~2.5 min) (Hill et al. 2007; Sale 
et al. 2011; Smith et al. 2009). Because carnosine returns 
slowly to baseline levels after beta-alanine supplementation 
is ceased (Baguet et al. 2009), effects of supplementation 
on exercise and training can be expected to last up to 
3 weeks or longer. thus, HIt and beta-alanine supplemen-
tation present two independent possibilities for positively 
affecting physiological determinants of exercise perfor-
mance in the severe domain and lasting a few minutes.
In addition to individual effects of HIt and beta-alanine 
on determinants of severe exercise performance, there could 
be additional benefits of combining the two. For example, 
one time-effective strategy when implementing HIt com-
prises several consecutive days of demanding interval train-
ing sessions within a short training block (Breil et al. 2010; 
gross et al. 2007; laursen et al. 2002; Stolen et al. 2005; 
Storen et al. 2012). During such blocks, exceptionally large 
loads of high-intensity training are essential for achieving 
training adaptations, and there is evidence that greater train-
ing loads can be tolerated with supplemental beta-alanine 
(Hoffman et al. 2008a, b). this improved tolerance for train-
ing stressors could be related to various effects of muscle 
carnosine. carnosine’s ability to curb acidosis and oxidative 
stress (Begum et al. 2005) could quicken recovery between 
intense exercise bouts and between demanding training ses-
sions, respectively. Further, carnosine could act to increase 
the threshold for neuromuscular fatigue, as shown by (Stout 
et al. 2007a, b) or counteract muscular fatigue, as implied 
by (Dutka and lamb 2004; Dutka et al. 2012), thus allowing 
for a better-sustained training intensity or volume. Addition-
ally, it is feasible that beta-alanine supplementation could 
also enhance training adaptations without affecting the 
training stimulus itself. For example, Bishop et al. (2010) 
showed reducing acidosis during HIt leads to greater 
mitochondrial adaptations in rat muscle, perhaps by pro-
moting net protein synthesis or promoting upregulation of 
Pgc-1α and other genes regulating mitochondrial biogen-
esis. Whereas protection against acidosis in that study was 
achieved via supplementation with the extracellular buffer 
sodium bicarbonate, increasing intramuscular pH buffering, 
via carnosine, could benefit training adaptations in a similar 
manner. thus, beta-alanine supplementation, by increasing 
the tolerance for intense training, could lead to more sub-
stantial training effects.
the aim of this two-part intervention study was to alter 
the physiological systems discussed above in ways that 
could improve severe exercise performance. We hypoth-
esized that (1) HIt, by improving VO2max and VO2 kinet-
ics, would enhance aerobic energy contribution during 
severe cycling exercise; (2) beta-alanine supplementation, 
by increasing intramuscular carnosine, would improve 
buffering capacity and reduce pH disturbance, or otherwise 
dampen muscle fatigue during severe cycling exercise; and 
(3) prior supplementation with beta-alanine would allow 
for greater training load and better recovery during HIt, 
which would enhance benefits of training on physiological 
determinants of severe exercise performance.
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Methods
Design
this study employed a controlled, non-crossover design. 
the study timeline is displayed in Fig. 1. the study dura-
tion was 12 weeks. During an initial 2-week baseline 
period, medical screening and exercise test familiarization 
were achieved, and subjects began documenting their train-
ing. thereafter, tests and measurements were performed at 
three time points (M1–M3), separated by two intervention 
phases. Phase 1 compared beta-alanine to a placebo; phase 
2 assessed the effects of HIt in beta-alanine and placebo 
groups.
Subjects and groups
Seventeen males, who participated regularly in endur-
ance, team, or combat sports, volunteered to participate 
in the study. Some participated in occasional recreational 
competitions (e.g., game sports, cycling, running, triath-
lon). Prior to a medical screening, they were informed of 
and signed informed written consent to all study proce-
dures, which had been approved by the Ethical review 
Board of the canton of Bern, Switzerland. Based on 
VO2max (ml/min/kg) measurements attained during med-
ical screening, matched pairs were randomly split into 
two groups. Subject characteristics are summarized in 
table 1.
Intervention
In the first intervention phase, orally supplemented beta-
alanine was compared to a placebo in a double-blind 
fashion. For a period of 38 days, one group (BAl, n = 8) 
consumed 3.2 g per day (4 doses of 800 mg) of purified 
beta-alanine (Harris et al. 2006), while the other group 
(PlA, n = 9) consumed the same dosage of maltodextrin, 
which served as a placebo. Supplements were provided as 
400-mg gel capsules (Pharma Futura SA, grône, Switzer-
land), and subjects were instructed to take doses at each of 
the three main meals and before going to sleep. Placebo 
and beta-alanine were distributed by an impartial person, 
and neither investigators nor subjects could differentiate 
the two, either visually or by taste. During this phase, nei-
ther dietary intake nor training was specifically controlled. 
Subjects continued training as they were accustomed, and 
logged all training. Diet was not monitored.
In the second intervention phase, supplementation was 
discontinued and BAl and PlA completed the same HIt 
block. this was similar to that used by Breil et al. (2010) 
and consisted of nine HIt sessions performed within 
11 days, performed and supervised in the lab. rest was 
allowed on days 4 and 8. Sessions were performed on a 
cycle ergometer and comprised a light 10-min warm-up 
followed by four 4-min intervals at the maximal sustain-
able power output. these intervals were intended to elicit 
heart rates (Hr) of 90–95 % of Hrmax, which was moni-
tored continuously (Polar Electro Oy, Kempele, Finland). 
Fig. 1  timeline of the study
Table 1  Subject characteristics
Data presented as mean ± SD. VO2max measured during medical screening. Percentage of type I muscle fibers (pct. type I) averaged across M1 
and M2, as values from these time points did not differ (p = 0.27)
Age (years) Height (cm) Weight (kg) VO2max (ml/kg/min) pct. type I (%)
BAl (n = 8) 32 ± 8 182 ± 7 77 ± 7 59 ± 5 69 ± 7
PlA (n = 9) 31 ± 8 180 ± 7 71 ± 6 61 ± 4 64 ± 13
All (n = 17) 31 ± 8 181 ± 6 74 ± 7 60 ± 5 67 ± 11
range (all) (23–45) (171–192) (64–85) (48–69) (48–88)
p groups 0.71 0.54 0.09 0.49 0.35
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Intervals were separated by 3 min of light cycling (no 
greater than 40 % PPO). Subjects from both groups trained 
together. Subjects were encouraged to increase training 
power output as much as possible throughout the train-
ing block. Subjects began the block in a normal state of 
recovery. Following the ninth HIt session, subjects were 
afforded 6 days of recovery, with the instruction to train 
only lightly so as to promote regeneration. this was con-
firmed by reviewing their training logs. Data gathered dur-
ing the HIt sessions included subjective state and motiva-
tion (on a 0–10 scale) prior to warm-up, power and ratings 
of perceived exertion (rPE) for each interval, and blood 
lactate (Bla) after the first and fourth intervals and Hr 
continually throughout the session.
tests/measurements
Body weight was taken at each time point (M1–M3) on a 
Quattrojump force plate (Kistler Instruments, Winterthur, 
Switzerland) and body fat percentage was estimated from 
seven skinfolds according to regression described by Jack-
son and Pollock (1978). As well, the following measure-
ments were made at each time point (see Fig. 1).
MRS
Muscle carnosine concentration ([carn]) was determined 
in m. tibialis anterior, m. gastrocnemius, m. vastus inter-
medius, and m. vastus lateralis using single voxel 1H-Mr 
spectroscopy on a 3 tesla Mr system (trIO, SIEMEnS 
Erlangen, germany). Following the acquisition of a local-
izer series, a high-resolution imaging series of the calf or 
thigh (Fast spin echo, echo train 19, tr = 2,660 ms, tE 
13 ms, slice 4 mm, pixel 0.625 × 0.625 mm) was acquired 
for the definitive placement of the MrS voxel. A standard 
flexible surface coil was used to obtain the high-resolution 
images and subsequent PrESS spectra (“point-resolved-
spectroscopy”, tr = 3,000 ms, tE = 30 ms). the default 
voxel size was set to 18 × 18 × 30 mm (left–right, Ante-
rior–Posterior, Head–Feet), but was adjusted in lr and AP 
direction in case of small cross section of the muscles or 
fatty infiltrations. Voxels were positioned with an accu-
racy of a few millimeters to minimize effects of variations 
in dipolar coupling effects (depending on the pennation 
angle) and tissue composition along the muscles. Dur-
ing the measurement, the leg was fixed in all three direc-
tions by a custom-made fixation device. ninety-six scans 
with the central frequency at the carnosine-H2 position 
(8.0 ppm, PrESS sequence of the vendor adapted) were 
followed by an unsuppressed water scan (n = 1) with the 
central frequency shifted to the water position to correct 
for the chemical shift displacement and to acquire exactly 
the same voxel for the metabolites and the water standard. 
Absolute quantification of [carn] was based on an unsup-
pressed water spectrum as described elsewhere (Stelling-
werff et al. 2012), using relaxation values from literature 
(Ozdemir et al. 2007).
Incremental cycling test
An incremental cycling test to exhaustion was performed 
on an Ergometrics 800S cycle ergometer (ergoline gmbH, 
Bitz, germany) for the determination of VO2max, peak 
power output (PPO), Hrmax, maximal blood lactate concen-
tration (Blamax) and PO at the second ventilatory threshold 
(P Vt2). Beginning at 70 W, power was increased stepwise 
by 30 W every 2 min, until volitional exhaustion or a ped-
aling cadence dropped below 60 rpm for three seconds. 
During the last 15 s of each stage and at exhaustion, Bla 
was measured at the finger (Biosen c-line sport, EKF-diag-
nostic gmbH, Barleben/Magdeburg, germany). Breath-by-
breath respiratory data were collected using an Oxycon Pro 
(Erich Jaeger gmbH, Höchberg, germany). Hr was meas-
ured continuously. VO2max was taken as the highest 30-s 
average of breath-by-breath data and confirmed when the 
corresponding respiratory exchange ratio was at least 1.1 
and blood lactate was at least 7.5 mmol/l. PPO was inter-
polated from the average P/t slope (i.e., 15 W/min) and 
time point at exhaustion. Blamax was taken at exhaustion. P 
Vt2 was identified by two independent investigators as the 
interpolated PO corresponding to the second breakpoint in 
the respiratory equivalents of O2 and cO2, i.e., minute ven-
tilation (Ve)/VO2 and Ve/VcO2, respectively (Dekerle et al. 
2003).
Fixed power test (FPT)
At least 24 h later, a fixed power, fixed duration (90 s) 
cycling test was performed using the equipment described 
above, for assessing oxygen deficit and proportions of 
aerobic and anaerobic energy contribution. After a 10-min 
warm-up at 40 % PPOM1, subjects cycled at 50 W and 
60 rpm for 3 min, to allow VO2 to level off (baseline 
phase). the baseline power output was chosen because it 
is the lowest at which the Ergoline can provide continuous 
resistance at 60 rpm. thereafter, cadence was increased to 
105 rpm and power was adjusted to 110 % PPOM1 within 
approximately 3 s. this was maintained for 90 s. Abso-
lute power output remained the same for M1–M3 (40 and 
110 % of PPO attained at M1). Blood lactate was meas-
ured 30 s before, 15 s after and 4 min after the 90-s test. 
the cadence during the test was chosen to ensure that sub-
jects could pedal smoothly and complete the exercise task 
with minimal upper body motion. VO2peak in the FPt was 
defined as the highest 15-s average of breath-by-breath 
data.
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Oxygen deficit was taken as the difference between O2 
consumption during the 90-s test and the estimated O2 
demand (Bangsbo et al. 1990). O2 consumption was the 
area under the curve of gross VO2 between 0 and 90 s (i.e., 
mean VO2·1.5 min). O2 demand at 110 % PPO was esti-
mated by interpolating data from the most recent incremen-
tal test (using stages prior to plateau in VO2 only) and cor-
recting the y-intercept based on steady-state VO2 during the 
warm-up prior to the FPt. the following equation was used 
for estimating O2 demand:
where m is the slope of the VO2/PO relationship (ml/
min/W) established from the most recent incremental test, 
b is the steady-state VO2 (ml/min) averaged over the second 
half of the warm-up preceding the 90-s test, and PO110 % 
and PO40 % are the power outputs (W) applied during test 
and warm-up, respectively. Finally, the percentage of aero-
bic energy contribution was calculated as O2 consumption/
O2 demand 100 %. In our lab, cV in this test for O2 con-
sumption, O2 deficit, and aerobic energy contribution are 
2 % (95 % cI ± 88 ml), 3 % (95 % cI ± 115 ml), and 2 % 
(95 % cI ± 1.1 percentage points), respectively (Märzen-
dorfer 2011).
Biopsy analyses
In combination with the 90-s FPt, two muscle biopsies 
from m. vastus lateralis were taken. Prior to warm-up, 
two incisions were made under local anesthesia induced 
with lidocaine, approximately 1 cm apart in the mid-thigh 
portion of m. vastus lateralis of the right leg, and the first 
(pre-exercise) biopsy was extracted using a Bergstrom nee-
dle (1975). A second (post-exercise) biopsy was extracted 
using a Pro-Mag 2.2 automatic biopsy instrument (MD 
tech, gainsville, Fl, USA) exactly 15 s after completion 
of the FPt. Both biopsies were immediately frozen in iso-
pentane cooled by liquid nitrogen, then preserved in liquid 
nitrogen until further analysis.
For M1 and M2 only, cross-sectional slices (12 μm) 
were stained for determining muscle fiber-type composi-
tion using procedures described by Billeter et al. (1980). 
Samples were pre-incubated at pH 4.75 instead of pH 4.35, 
as this produced better contrast in pilot stains. Stained sam-
ples were photographed with 20× magnification (color-
View 3U ccD color camera in a leica DMrB light 
microscope). First, fibers were visually classified as type I, 
IIA or IIX. then, to determine fiber-specific cross-sectional 
area (cSA), photos were overlaid with a 30 × 30 μm grid 
using cell^D software (version 3.4, Olympus Soft Imag-
ing Solutions, gmbH), and intersection points on clas-
sified type I and IIA and IIX fibers showing no ellipticity 
were counted manually, according to Weibel (1979). In all, 
O2 demand = [m · PO110 % + (b − m · PO40 %)] · 1.5 min
153 ± 104 and 128 ± 62 fibers per subject were analyzed 
for M1 and M2, respectively.
For M1–M3, portions of resting and post-exercise biop-
sies were freeze-dried, dissected under a microscope until 
freed from blood and connective tissue, and weighed for 
analysis of muscle pH, buffering capacity, muscle lactate, 
glycogen, and enzyme activities (see below).
One portion of freeze-dried muscle (1–9 mg) was desig-
nated for determination of muscle pH and buffering capac-
ity, based on the methods of Bishop et al. (2008). In short, 
muscle was homogenized by hand on ice in a 10-mM naF 
solution at a dilution of 30-mg muscle/ml solution. twenty-
five- or 30-μl portions were transferred to Eppendorf 
tubes, vortexed, and warmed to 37 °c on a thermomixer 
(Vadaux-Eppendorf, Basel, Switzerland) for measurement 
of pH using a microelectrode (MI-410, Microelectrodes 
Inc., USA) connected to a pH meter (Model 320, Mettler-
toledo, USA) double-calibrated at pH 7.0 and 4.01. After 
initial pH determination, solutions from pre-exercise sam-
ples were titrated with 10-mM Hcl until pH decreased to 
6.3; pH was measured after each 2 μl addition of Hcl, and 
the mean slope was calculated from the serial pH measure-
ments and normalized to express muscle buffering capacity 
in terms of mmol H+/kg dry muscle/pH unit.
Another portion (0.7–6.8 mg) was submerged in 0.4-M 
HclO4 on ice and broken into small pieces by hand to 
extract metabolites. After 20 min, the solution was neutral-
ized using 2-M KHcO3 and centrifuged for 10 s. Muscle 
lactate was analyzed in the supernatant by a fluorometric 
enzymatic method (lowry and Passonneau 1972).
Another portion (0.5–8 mg) was homogenized in 
400 μl/mg 0.1-M phosphate buffer at pH 7.7 with 0.5 % 
bovine serum albumin. ten μl homogenate was mixed 
with 40 μl 1.5-M Hcl and incubated for 1.5 h at 100° c 
to break down glycogen into glycosyl units. After cool-
ing, glycogen concentration was quantified via glucose by 
a fluorometric enzymatic method (lowry and Passonneau 
1972). Separately, portions of the same homogenate were 
used for determining activities of citrate synthase (cS) and 
phosphofructokinase (Pfk), using a fluorometric enzymatic 
method (lowry and Passonneau 1972).
Monitoring tools
throughout the study, subjects kept a training log including 
total exercise time and perceived intensity (0–10 scale) for 
calculation of training volume and load according to Foster 
et al. (2001). logged training sessions were categorized into 
intensity zones I, II, and III based on reported session rPE 
(Seiler and Kjerland 2006), and training descriptives were 
evaluated based on these zones. Subjects also documented 
their dose-by-dose intake of the supplement in their training 
logs, from which supplement compliance was quantified.
226 Eur J Appl Physiol (2014) 114:221–234
1 3
Data analysis
All results are reported as mean ± SD. the main vari-
ables were initially assessed for interactions using 2 × 3 
(group time) AnOVA (SPSS, Version 20, IBM). Within-
group changes, as well as changes in the pooled cohort, 
were assessed thereafter (post hoc) across each interven-
tion phase using repeated-measures t tests. Additionally, 
independent t tests on individual deltas values were per-
formed. For t tests, no correction for multiple comparisons 
was made (Hopkins et al. 2009; Perneger 1998). For some 
variables, changes were compared between phases using 
repeated-measures t tests. training data from subjects’ 
training logs and HIt sessions were compared between 
groups using independent t tests. the alpha level for signif-
icance was set at 0.05. cohen’s effect sizes (d) were calcu-
lated as the ratio of mean change to the standard deviation 
of initial values. Finally, observed power of the AnOVA 
(calculated using SPSS, α = 0.05) are reported for the main 
variables.
Results
All subjects remained in the study through M2. One subject 
from BAl dropped out of the study between M2 and M3, 
while another from BAl could not complete the incremen-
tal test at M3 due to sickness. Accordingly, effects across 
phase 2 were analyzed with a reduced n in BAl, as noted in 
the text and tables. there were no changes in bodyweight 
or body composition for either group at any time point dur-
ing the study (all p > 0.14).
Supplement compliance and muscle carnosine
According to subjects’ documentation, supplement com-
pliance was 99.4 ± 1.7 % in BAl and 99.9 ± 0.2 % in 
PlA. Due to limited availability of the Mr, MrS could 
be performed on only 14 subjects. Prior to supplementa-
tion, there were differences in mean [carn] between the 
four measured muscles, namely m. gastroc. > (p < 0.01) 
m. vast. lat. > (p = 0.12) m. tib. ant. > (p < 0.01) m. vast. 
int. In BAl, significant increases in all four muscles (+24 
to 49 %) occurred with supplementation (table 2). Per-
cent changes in [carn] with beta-alanine supplementation 
were not uniform in the four muscles, as can be seen in 
table 2. Between M1 and M2, the relative increase in m. 
vast. int. (+49 ± 27 %) was significantly greater than in 
m. gastroc. (+24 ± 14 %) and m. vast. lat. (+25 ± 10 %). 
As well, increases in m. tib. ant. (+37 ± 12 %) were sig-
nificantly greater than in m. gastroc. and m. vast. lat. (all 
p values from repeated-measures t tests <0.05). Although 
[carn] of BAl dropped significantly between M2 and M3 
in m. vast. int. (p = 0.01) and m. vast. lat. (p = 0.04), it 
remained 19–33 % higher at M3 than at M1 (p ≤ 0.01) 
in all muscles. there were no changes in [carn] at any 
time in PlA (n = 7), and the group time interaction was 
significant (p from AnOVA < 0.01) for all muscles. Del-
tas at M2 and M3 (at each time point compared to M1) 
were significantly greater for BAl than PlA in all mus-
cles (p < 0.01), except for m. vast.int. at M3 (p = 0.09). 
Observed power for [carn] in the various muscles ranged 
from 0.97 to 1.00.
Muscle histochemistry
there were no significant differences in fiber-type distri-
bution between groups at M1 (p > 0.33) or M2 (p > 0.13) 
and no changes occurred in either group between M1 
and M2 (p from AnOVA 0.66). On average, subjects had 
66 ± 12 % (range 48–89 %) type I, 26 ± 12 % (4.6–52 %) 
type IIA, and 7.3 ± 7.8 % (0.0–26 %) type IIX muscle 
fibers. there was no interaction effect for muscle fiber 
cSA (p from AnOVA 0.25, observed power 0.40). How-
ever, cSA increased significantly in BAl in type I fibers 
(+16 ± 12 %, p = 0.01), whereas changes in type IIA 
(p = 0.18) and IIX (p = 0.16) fibers were not significant. 
there were no changes in cSA for PlA. table 3 displays 
cSA data after removing outliers (values or deltas greater 
than two standard deviations from the mean).
Table 2  changes in muscle 
carnosine by group
Data presented as mean ± SD 
(n)
* p < 0.05, ** p < 0.01 from 
repeated-measures t test, 
compared to M1. §p < 0.05, 
compared to M2. #p < 0.05 
compared to BAl at same time 
point
Muscle carnosine content (mmol/kg wet weight)
m. tib. ant. m. gastroc. m. vast. int. m. vast. lat.
BAl
 M1 6.9 ± 0.8 (7) 8.8 ± 1.0 (7) 5.6 ± 1.1 (7) 7.4 ± 1.6 (7)
 M2 9.4 ± 0.8 (7)** 10.8 ± 1.1 (7)** 8.2 ± 1.1 (7)** 9.2 ± 1.4 (7)**
 M3 8.8 ± 1.1 (6)** 10.5 ± 1.1 (6)** 7.2 ± 1.0 (6)**§ 8.6 ± 1.2 (6)**§
PlA
 M1 6.8 ± 1.1 (7) 9.6 ± 1.2 (7) 5.7 ± 1.3 (7) 7.1 ± 0.7 (7)
 M2 7.1 ± 0.9 (7)# 9.2 ± 1.6 (7)# 6.1 ± 1.0 (7)# 7.2 ± 1.0 (7)#
 M3 6.9 ± 1.1 (7)# 9.2 ± 1.7 (7) 6.6 ± 0.9 (7) 7.0 ± 1.0 (7)#
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Maximal incremental performance
Values from the incremental test are presented in table 4. 
there was no interaction effect (p from AnOVA ≥ 0.40), 
and there were no effects of supplementation within either 
group between M1 and M2. there were, however, small 
but significant increases for the cohort as a whole for PPO 
(+2.2 ± 3.9 %, p = 0.05, d = 0.2, n = 17) and PO at Vt2 
(+3.7 ± 6.9 %, p = 0.04, d = 0.3, n = 17), but not VO2max. 
In addition, between M2 and M3 there was a small signifi-
cant increase for the entire cohort on PPO (+3.7 ± 4.2 %, 
p = 0.01, d = 0.3, n = 15) with no change in VO2max. 
repeated-measures t test on the PPO deltas revealed that 
changes across the HIt phase were not different from those 
across the supplementation phases (p = 0.56, n = 15). 
Between M2 and M3, there was no interaction effect on 
Blamax (p from AnOVA 0.18); however, there was an 
increase in PlA (+18 ± 10 %, p < 0.01, d = 1.0, n = 9) 
but not in BAl (+5.1 ± 13.0 %, p = 0.35, d = 0.3, n = 8).
Physiological determinants of severe exercise performance
Data from the FPt are displayed in table 5. there were 
no significant interactions for any FPt parameters. How-
ever, following supplementation, O2 deficit was reduced 
(−5.0 ± 5.0 %, p = 0.02, d = 0.6, n = 8) and aerobic 
energy contribution increased (1.4 ± 1.3 %, p = 0.02, 
d = 0.5, n = 8) in BAl, whereas no change occurred in 
either parameter in PlA. Blood lactate 4-min post-exer-
cise (−8.2 ± 10.5 %, p = 0.06, d = 0.6, n = 8) and post-
exercise muscle lactate (−21 ± 29 %, p = 0.06, d = 0.8, 
n = 8) displayed strong tendencies for being decreased 
in BAl only, and there was a significant decrease in 
exercise-induced muscle lactate accumulation in BAl 
Table 3  Muscle fiber cross-sectional area by fiber type
Values from the only two subjects in BAl having type IIX fibers at both time points were considered outliers. Data presented as mean ± SD (n)
* p ≤ 0.05 from repeated-measures t test, compared to M1
All fibers type I type IIA type IIX
BAl
 M1 6,231 ± 967 (6) 6,034 ± 1,015 (6) 6,779 ± 1,087 (6) n.a.
 M2 7,014 ± 731 (6)* 6,946 ± 724 (6)* 7,330 ± 1,177 (6)
PlA
 M1 6,576 ± 1,284 (6) 6,403 ± 1,623 (6) 7,459 ± 1,419 (6) 4,707 ± 1,125 (3)
 M2 6,123 ± 657 (6) 5,923 ± 620 (6) 6,713 ± 1,085 (6) 6,418 ± 1,245 (3)
Table 4  Parameters from 
maximal incremental cycling 
test
Data presented as mean ± SD 
(n)
Bold values indicate statistical 
significance (p < 0.05)
PPO peak power output, BLamax 
maximal blood lactate, P VT2 
power at second ventilatory 
threshold
VO2max (ml/min/kg) PPO (W) Blamax (mmol/l) P Vt2 (W)
BAl
 t1 57.4 ± 4.0 (8) 332 ± 30 (8) 12.0 ± 3.6 (8) 242 ± 24 (8)
 p time 0.37 0.16 0.23 0.40
 t2 58.2 ± 4.9 (8) 342 ± 40 (8) 12.5 ± 2.6 (8) 246 ± 25 (8)
 p time 0.92 0.48 0.35 0.18
 t3 59.8 ± 4.2 (6) 362 ± 27 (6) 13.4 ± 3.4 (6) 265 ± 14 (6)
PlA
 t1 58.1 ± 4.3 (9) 322 ± 49 (9) 11.3 ± 1.6 (9) 234 ± 36 (9)
 p time 0.76 0.18 0.33 0.06
 t2 57.8 ± 3.9 (9) 326 ± 43 (9) 10.7 ± 2.5 (9) 246 ± 40 (9)
 p time 0.18 <0.01 <0.01 0.41
 t3 59.6 ± 4.5 (9) 342 ± 44 (9) 13.2 ± 2.3 (9) 253 ± 31 (9)
group time AnOVA
 p 0.40 0.29 0.18 0.84
 Power 0.20 0.26 0.34 0.07
Intergroup p on deltas
 t1–t2 0.39 0.43 0.14 0.31
 t2–t3 0.32 0.13 0.06 0.93
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following supplementation (−23 ± 30 %, p = 0.05, 
d = 0.9, n = 8), but not PlA. Between M2 and M3, 
effects seen for these parameters in BAl diminished 
non-significantly toward pre-supplementation values, 
such that there were no significant differences between 
M1 and M3.
Table 5  Metabolic mechanisms during severe intensity exercise
Data presented as mean ± SD (n). cycling test comprised 90 s at 110 % PPO
Bold values indicate statistical significance (p < 0.05)
E aerobic aerobic contribution to energy, BLa 4′ blood lactate 4-min post-exercise, MLa muscle lactate, Δ MLa muscle lactate accumulation 
pre- to post-exercise, τ on time constant of VO2 on-kinetics
O2 deficit (ml) E aerobic (%) Bla 4′ (mmol/l) Mla (mmol/kg d.w.) Δ Mla (%)
BAl
 t1 2,587 ± 199 (8) 64.8 ± 2.6 (8) 8.8 ± 1.1 (8) 51 ± 17 (8) 47 ± 16 (8)
 p time 0.02 0.02 0.06 0.06 0.05
 t2 2,461 ± 271 (8) 66.1 ± 3.2 (8) 8.0 ± 1.2 (8) 37 ± 10 (8) 33 ± 12 (8)
 p time 0.54 0.60 0.77 0.26 0.30
 t3 2,542 ± 217 (7) 65.7 ± 2.2 (7) 8.2 ± 1.9 (7) 43 ± 13 (7) 39 ± 14 (7)
PlA
 t1 2,210 ± 488 (9) 68.1 ± 5.1 (9) 9.0 ± 1.0 (9) 43 ± 31 (8) 39 ± 31 (8)
 p time 0.74 0.99 0.38 0.81 0.87
 t2 2,170 ± 417 (9) 68.0 ± 4.0 (9) 8.7 ± 0.9 (9) 47 ± 14 (9) 41 ± 13 (9)
 p time 1.00 0.88 0.02 0.51 0.46
 t3 2,170 ± 366 (9) 67.9 ± 3.3 (9) 8.0 ± 0.7 (9) 40 ± 15 (9) 34 ± 15 (8)
group time AnOVA
 p 0.91 0.71 0.25 0.58 0.59
 Power 0.06 0.10 0.29 0.13 0.13
Intergroup p on deltas
 t1–t2 0.51 0.31 0.43 0.18 0.20
 t2–t3 0.71 0.84 0.07 0.22 0.20
Table 6  Muscle pH and 
buffering capacity
Data presented as mean ± SD 
(n)
Bold values indicate statistical 
significance (p < 0.05)
pH pre-exercise pH post-exercise Buffering capacity
BAl
 t1 7.01 ± 0.05 (8) 6.76 ± 0.07 (8) 180 ± 21 (8)
 p time 0.27 0.30 0.54
 t2 7.06 ± 0.11 (8) 6.80 ± 0.07 (8) 174 ± 19 (8)
 p time 0.71 0.39 0.57
 t3 7.02 ± 0.10 (7) 6.82 ± 0.12 (7) 184 ± 20 (5)
PlA
 t1 7.03 ± 0.13 (9) 6.77 ± 0.10 (9) 184 ± 15 (9)
 p time 0.59 0.06 0.20
 t2 7.07 ± 0.14 (9) 6.89 ± 0.18 (9) 172 ± 23 (9)
 p time 0.45 0.94 0.01
 t3 7.02 ± 0.07 (9) 6.88 ± 0.15 (9) 186 ± 25 (9)
group time AnOVA
 p 0.92 0.41 0.85
 Power 0.06 0.19 0.07
Intergroup p on deltas
 t1–t2 0.94 0.25 0.61
 t2–t3 0.59 0.57 0.64
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there were no interaction or time effects of supplemen-
tation or HIt on post-exercise muscle pH in BAl or PlA, 
or on exercise-induced pH change (table 6). there was no 
interaction effect on buffering capacity. However, although 
muscle buffering capacity was not affected by supplemen-
tation in either group or in the pooled cohort, this increased 
significantly in the pooled cohort in response to HIt 
(+7.9 ± 11.9 %, p = 0.04, d = 0.6, n = 14). the change 
in buffering capacity in the HIt phase was significantly 
greater than during the supplementation phase (repeated-
measures t test on deltas: p = 0.03).
there were no intragroup or interaction effects on rest-
ing glycogen or glycogen usage during the FPt. However, 
resting muscle glycogen increased in the pooled cohort in 
response to HIt (+30 ± 47 %, p = 0.04, d = 0.5, n = 16), 
with no differences in the response between groups. Simi-
larly, post-exercise glycogen was higher after HIt, regard-
less of group, (+41 ± 35 %, p < 0.01, d = 1.4, n = 16), but 
no significant effect was apparent on net glycogen usage 
during the FPt. glycogen data are presented in table 7.
there were no changes in cS activity during the study 
and no interaction effect on PFK activity. However, there 
was a decrease in Pfk activity following supplementation 
in BAl (−18 ± 17 %, p = 0.03, d = 1.4, n = 8), but not in 
PlA (table 8).
normal training and HIt block
there were no changes in training habits of either BAl 
or PlA across the supplementation period, nor were there 
any differences between groups during baseline or supple-
mentation. compared to the supplementation period, there 
were significant increases during the HIt block (pooled 
data, n = 16, no interaction or intergroup differences) in 
the weekly number of training sessions performed in zone 
III (from 0.8 ± 0.9 to 3.8 ± 0.3), weekly zone III train-
ing volume (from 62 ± 84 to 142 ± 41 min) and in the 
typical session rPE (from 7.5 ± 0.5 to 8.9 ± 0.7) for 
zone III sessions (all p < 0.01). Weekly training load in 
zone III (volume × rPE) increased from 477 ± 650 to 
1,272 ± 405, (p < 0.01) between supplementation and HIt 
phases. Accordingly, weekly training frequency, volume 
and load in zones I and II were all significantly reduced. 
Overall training frequency and load did not differ between 
phases, but total volume was reduced from 491 ± 238 dur-
ing supplementation to 288 ± 177 min/weeks during HIt, 
(p < 0.01).
During HIt, subjects always selected the highest tol-
erable power output, which increased from 266 ± 33 to 
294 ± 38 W (p < 0.01, n = 16) between the first and last 
HIt sessions. Overall training PO did not differ between 
Table 7  Muscle glycogen content
Data presented as mean ± SD (n)
Bold values indicate statistical significance (p < 0.05)
glycogen pre- 
exercise (mmol/ 
kg d.w.)
glycogen post-
exercise (mmol/
kg d.w.)
BAl
 t1 525 ± 131 (8) 409 ± 67 (8)
 p time 0.57 0.92
 t2 488 ± 113 (8) 406 ± 120 (8)
 p time 0.05 0.02
 t3 612 ± 178 (7) 545 ± 159 (7)
PlA
 t1 559 ± 94 (9) 384 ± 138 (9)
 p time 0.33 0.41
 t2 482 ± 203 (9) 340 ± 50 (9)
 p time 0.31 0.01
 t3 547 ± 90 (9) 481 ± 117 (9)
group time AnOVA
 p 0.63 0.77
 Power 0.12 0.09
Intergroup p on deltas
 t1–t2 0.70 0.51
 t2–t3 0.56 0.92
Table 8  Muscle enzyme activity
Data presented as mean ± SD (n)
Bold values indicate statistical significance (p < 0.05)
CS citrate synthase, Pfk phosphofructokinase
cS (mmol nADH/
kg d.w./min)
Pfk (mmol nAD+/
kg d.w./min)
BAl
 t1 20.95 ± 6.63 (8) 13.21 ± 7.01 (8)
 p time 0.50 0.03
 t2 19.27 ± 4.89 (8) 10.31 ± 4.86 (8)
 p time 0.90 0.76
 t3 21.06 ± 6.60 (6) 10.30 ± 4.06 (7)
PlA
 t1 18.65 ± 2.29 (9) 13.87 ± 6.51 (9)
 p time 0.88 0.58
 t2 18.28 ± 6.55 (9) 14.77 ± 7.92 (9)
 p time 0.28 0.87
 t3 21.14 ± 6.31 (9) 15.05 ± 8.46 (9)
group time AnOVA
 p 0.57 0.12
 Power 0.13 0.42
Intergroup p on deltas
 t1–t2 0.71 0.07
 t2–t3 0.42 0.75
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groups (pooled mean 84.4 ± 5.7 % PPO, intergroup 
p > 0.9) and both groups increased training PO simi-
larly from the second to the ninth session (pooled mean 
3.9 ± 2.7 % PPO, intergroup p = 0.70). However, when 
asked prior to HIt sessions, BAl reported higher subjec-
tive state (8.1 ± 0.5, n = 63) and motivation (9.3 ± 0.5, 
n = 63) compared to PlA (7.3 ± 0.7, and 8.4 ± 0.7, 
respectively, n = 81, both p = 0.01). Moreover, PlA 
achieved higher peak Hr (95.4 ± 1.2 % Hrmax, n = 9) and 
spent overall more time above 90 % Hrmax (115 ± 11 min, 
n = 9) during HIt compared to BAl (93.6 ± 1.0 % Hrmax, 
93 ± 17 min, n = 7, both between groups p = 0.01). 
there were no group differences in rPE or blood lactate 
responses during HIt sessions.
Discussion
this study investigated the hypothesis that a short HIt 
block and beta-alanine supplementation would each posi-
tively affect physiological determinants of severe exercise, 
and that combining the two would yield additional benefits. 
Our main findings were that (1) beta-alanine supplementa-
tion increased muscle carnosine, enhanced aerobic energy 
contribution during severe cycling exercise, and had posi-
tive effects on motivation during an intense HIt block; 
(2) significant increases in muscle carnosine did not affect 
the muscle homogenate buffering capacity or pH changes 
during severe cycling exercise; (3) an 11-day HIt block 
increased the muscle buffering capacity and glycogen stor-
age, but did not enhance the aerobic energy contribution 
during severe cycling exercise; and (4) prior supplementa-
tion with beta-alanine was associated with greater increases 
in training intensity, but similar HIt-specific adaptations 
(improved buffering capacity and glycogen storage), com-
pared to placebo.
One limitation of our study is that we chose a test of 
fixed intensity and duration rather than an open-ended per-
formance test, while this allowed a better comparison of 
physiological determinants of severe exercise performance, 
effects on true performance capacity can only be inferred. 
Further, in the 90-s FPt, acidosis was less severe than has 
been observed elsewhere (pH ~6.50, table 6) (e.g., Mes-
sonnier et al. 2007), which was a result of the test being 
designed to ensure all subjects would finish. Further, the 
HIt intervention did not induce physiological adaptations 
in the magnitude we had expected (Breil et al. 2010; Hel-
gerud et al. 2007; Stolen et al. 2005); had there been a sub-
stantial increase in VO2max following HIt, conclusions 
about the effects of beta-alanine supplementation on train-
ing adaptations could have been made with more certainty. 
A possible technical limitation was that we adopted relaxa-
tion times from literature in the quantification of [carn], 
which could be influenced by changes in the individual 
relaxation times; however, these effects are assumed to be 
minimal and smaller than the observed changes.
As expected, [carn] increased significantly in BAl. 
While greater increases to [carn] have been reported in 
studies using higher daily doses or longer supplementa-
tion phases (Derave et al. 2007; Harris et al. 2006; Hill 
et al. 2007; Kendrick et al. 2008), our prescription of 3.2 g/
days for 6 weeks elicited changes similar to those reported 
after higher dosages elsewhere for m. tib. ant. (Baguet 
et al. 2009) and m. gastroc. (Baguet et al. 2009, 2010a). 
Ours is the first study to determine [carn] in the quadriceps 
using non-invasive MrS; assuming ~75 % water weight in 
skeletal muscle biopsies (personal observation), our val-
ues of 7.3 ± 1.2 mmol/kg w.w. in m. vast. lat. agree well 
with those reported elsewhere from muscle biopsies (22–
28 mmol/kg d.w.) (Harris et al. 2006; Hill et al. 2007; Ken-
drick et al. 2008). Moreover, we are the first to report val-
ues for m. vast. int., which were initially significantly lower 
than for m. vast. lat. (p < 0.01), but increased to a greater 
relative degree (28.1 ± 9.6 vs. 17.9 ± 5.1 %). this is prob-
ably due to a greater proportion of type I fibers in m. vast. 
int. than for m. vast. lat. (Edgerton et al. 1975; Hill et al. 
2007). In accord with Baguet et al. (2009) A similar pat-
tern was seen when comparing lower leg muscles, namely 
lower initial [carn] but greater relative increases in m. tib. 
ant., which typically has a greater proportion of type I fib-
ers (Johnson et al. 1973), compared to m. gastroc.
We observed an increase in muscle fiber cross-sectional 
area in type I fibers following beta-alanine supplementation. 
Although this has not been reported previously, beta-alanine 
(Hammer and Baltz 2003) and histidine compounds includ-
ing carnosine (Baslow 1998) are known to act as organic 
hydrophilic osmolytes. therefore, we believe the increase in 
cSA can be attributed to fluid influx due to higher than nor-
mal levels of myocellular beta-alanine or carnosine.
Despite increased [carn], beta-alanine did not improve 
maximal incremental cycling performance, as has been 
reported elsewhere (Smith et al. 2009; Stout et al. 2007a). 
Moreover, increased [carn] did not affect the buffering 
capacity or pH disturbance during a 90-s severe cycling 
bout, which was contrary to our hypothesis. Although Hill 
et al. supposed that increased buffering capacity must have 
been behind improved exercise capacity at 110 % PPO 
after beta-alanine supplementation (2007), measurements 
of buffering capacity or pH in muscle biopsies have not 
been published previously, although one study reported 
reduced acidosis in blood during a 6-min submaximal exer-
cise bout following beta-alanine supplementation (Baguet 
et al. 2010b). Our findings suggest that improved capac-
ity for severe exercise after beta-alanine supplementation 
(Hill et al. 2007; Sale et al. 2011; Smith et al. 2009) could 
instead be due to other mechanisms.
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Indeed, multiple indicators of severe exercise metabo-
lism were altered in BAl following supplementation. For 
the same amount of mechanical work, oxygen deficit and 
muscle lactate accumulation were significantly reduced, 
while blood lactate accumulation decreased slightly. real-
izing that the oxygen deficit may not represent the anaero-
bic energy turnover per se (Bangsbo 1998), but taking it to 
be a reliable indicator thereof (Stirling et al. 2008), we take 
these results to be indicative of enhanced oxidative energy 
provision and reduced reliance on substrate-level phospho-
rylation at the same severe intensity in BAl at M2. Pre-
viously, addition of carnosine has been shown to enhance 
muscle activity, in vitro (Boldyrev 2012) and in vivo in 
animals (Stvolinskii et al. 1992). For example, rats injected 
with carnosine ran 25–30 % longer while accumulating less 
lactate than control animals (Stvolinskii et al. 1992), due 
perhaps to reduced energy expenditure per unit work or 
improved mitochondrial coupling (Boldyrev 2012). Obser-
vations of such effects (termed “Severin’s phenomenon”) 
are not new, but have received relatively little appreciation 
in recent exercise-related studies of carnosine (an excep-
tion being the work of Dutka and lamb 2004; Dutka et al. 
2012) and Everaert et al. (2013). these provide evidence 
for an enhancing effect of carnosine on ca2+ release in 
human type I fibers and ca2+ sensitivity of the contrac-
tile apparatus in both fiber types (Dutka et al. 2012) and 
improved fatigue resistance (Everaert et al. 2013) in mouse 
slow-twitch muscle fibers. Although our test was of fixed 
power and duration, enhanced oxidative energy provision 
and slower accumulation of glycolytic metabolites which 
coincide with fatigue are consistent with this phenome-
non, and could reveal a mechanism behind improvements 
in cycling capacity at 110 % PPO reported elsewhere fol-
lowing beta-alanine supplementation (Hill et al. 2007; Sale 
et al. 2011; Smith et al. 2009).
Finally, we observed intergroup differences in training 
motivation and training Hr during the HIt block. BAl, 
who performed the training directly following beta-ala-
nine supplementation and with elevated [carn], reported 
consistently higher subjective states and motivation prior 
to HIt sessions, which suggests that they felt they could 
recover better between sessions than PlA. Similarly, Hoff-
man et al. (2008b) reported reduced feelings of fatigue in 
football players supplemented with beta-alanine. Animal 
experiments have reported anti-anxiety effects of beta-ala-
nine supplements (Murakami and Furuse 2010) and antide-
pressive effects of carnosine (tomonaga et al. 2008) with 
the substances affecting the brain directly in both cases. 
As we made no such measurements, it is unclear whether 
our findings relate to direct effects on the brain, perception 
of altered physiology (discussed below), or a combination 
of both. On the other hand, PlA achieved higher training 
Hr and spent more time in the target zone (>90 % Hrmax) 
than BAl. While similar observations of increased training 
load and reduced perceived fatigue have been reported pre-
viously (Hoffman et al. 2008a, b), this nonetheless had no 
influence on the outcome of the HIt block, which were the 
same for both groups.
We chose not to continue supplementation during the 
HIt block, based on the slow washout time of carnosine 
after induced expansion (Baguet et al. 2009). Although car-
nosine decayed slowly across the second phase as expected, 
metabolic effects of supplementation observed in BAl at 
M2 were no longer significant at M3. thus, it is possible 
that greater increases in [carn] or extending supplemen-
tation until M3 could have affected the outcome of HIt. 
Alternatively, the shift in energy production back toward 
greater reliance on anaerobic glycolysis could have been 
related to small effects on buffering capacity (which we, 
however, did not measure) following HIt (Parkhouse and 
McKenzie 1984). nonetheless, our finding that beta-ala-
nine did not improve training adaptations is consistent with 
other studies (Hoffman et al. 2008a; Walter et al. 2010). If 
this is the case, it provides further evidence that carnosine 
affects high-intensity muscle function primarily by means 
other than improved acid buffering, since augmenting 
extramuscular buffers appears to benefit adaptations to HIt 
(Bishop et al. 2010).
In contrast to our hypothesis, HIt did not increase 
VO2max, or P Vt2. Although there was a significant 
increase in PPO following HIt, this was no larger than that 
which occurred between M1 and M2. there was also no 
effect of HIt on aerobic energy contribution during severe 
cycling, also contrary to our hypothesis. Several previous 
studies have shown large improvements in VO2max after 
HIt in subjects of similar or greater training status and 
using intervals similar to those in the present study (Billat 
et al. 2002; Breil et al. 2010; Demarle et al. 2001; gross 
et al. 2007; Vanhatalo et al. 2008; Weston et al. 1997). In 
particular, Breil et al. (2010), one of the only other pub-
lished studies to employ such a concentrated phase of 
HIt, showed that VO2max was increased by 3 % two days 
after an 11-day HIt block, but by 6 % following 5 addi-
tional days of recovery. this reveals that recovery is a very 
important factor for the effectiveness of HIt block perio-
dization, and it is possible that our subjects were not fully 
recovered at the time of M3 testing. On the other hand, 
our HIt Block comprised fewer sessions than that of Breil 
et al. (2010) (nine compared to 15), while sessions were 
of less total volume at a high-intensity compared to other 
studies using longer, less condensed HIt periods (Demarle 
et al. 2001; gross et al. 2007; Weston et al. 1997). thus, 
it is possible that our intervention was not sufficient to 
elicit noticeable changes in VO2max in the present group 
of subjects. nonetheless, HIt had two important effects, 
the first being an increase in muscle glycogen storage, the 
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other an increase in muscle buffering capacity. Our finding 
of increased muscle glycogen concentration, in resting and 
post-exercise biopsies after HIt is consistent with other 
reports of increased muscle glycogen storage after intense 
endurance (Perry et al. 2008) or sprint (gibala and Mcgee 
2008) training or an 11-day HIt block (unpublished data 
from our lab). this adaptation should translate to improved 
endurance (rauch et al. 1995) and repeated-sprint (rock-
well et al. 2003; Skein et al. 2012) performance, and is 
clearly advantageous for athletes with especially frequent, 
long, or intense training sessions or competitions. In PlA, 
there was an increase in PPO between M2 and M2, coin-
cident with increased Blamax in the incremental test. this 
improvement in the power output at volitional exhaustion 
was evidently not related to improved aerobic condition, 
as there were no changes in VO2max in the incremental or 
aerobic energy contribution and lactate accumulation at the 
same absolute power output in the FPt.
the other main effect of HIt was a 7.9 % increase in 
muscle buffering capacity. this increase had no effect 
on pH disturbance during the FPt, but is relatively small 
compared to the 17 % improvement in buffering capacity 
after six interval sessions of similar intensity, but greater 
volume (total 30–40 min of intervals per session) reported 
by Weston et al. (1997) or a 25 % increase in buffering 
capacity of elite junior alpine skiers following an 11-day, 
15-session HIt block (unpublished data from our lab). the 
greater effects in those studies could be due to the larger 
training volume at high-intensity. Despite a small effect 
size (d = 0.5) in the present study, it is noteworthy that 
this improvement was significant whereas the supplement 
beta-alanine, in contrast to our hypothesis, had no such 
effect. Practicians aiming to enhance the buffering capac-
ity should, therefore, first consider short training interven-
tions, as shown here and elsewhere (Edge et al. 2006; Wes-
ton et al. 1997), before reaching for oral sport supplements 
such as beta-alanine.
In conclusion, beta-alanine could be useful for enhanc-
ing aerobic energy contribution during severe exercise, or 
supporting energy balance and psychological stability dur-
ing intense training phases. In addition, we recommend 
short blocks of HIt for athletes performing repeated-sprint 
activities, where glycogen depletion and acidosis limit the 
performance (Bishop et al. 2004; girard et al. 2011). In 
future work, it will be interesting to explore the location 
and mechanism of changes in severe exercise energy provi-
sion and how these perhaps relate to effects of carnosine on 
muscle contractility.
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